A detailed history of Td Private Client Wealth LLC transactions in Genmab A/S stock. As of the latest transaction made, Td Private Client Wealth LLC holds 13,854 shares of GMAB stock, worth $319,750. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,854
Holding current value
$319,750
% of portfolio
0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.13 - $30.27 $348,151 - $419,360
13,854 New
13,854 $348 Million
Q1 2024

Aug 16, 2024

BUY
$26.43 - $32.77 $29,073 - $36,047
1,100 Added 8.67%
13,783 $412 Million
Q4 2023

Aug 16, 2024

BUY
$27.94 - $35.44 $216,171 - $274,199
7,737 Added 156.43%
12,683 $404 Million
Q3 2023

Aug 16, 2024

BUY
$35.27 - $42.24 $95,863 - $114,808
2,718 Added 121.99%
4,946 $174 Million
Q2 2023

Aug 16, 2024

BUY
$37.4 - $42.94 $13,464 - $15,458
360 Added 19.27%
2,228 $84.7 Million
Q1 2023

Aug 16, 2024

SELL
$34.88 - $43.22 $130,032 - $161,124
-3,728 Reduced 66.62%
1,868 $70.5 Million
Q4 2022

Aug 16, 2024

BUY
$33.8 - $47.06 $10,849 - $15,106
321 Added 6.09%
5,596 $237 Million
Q3 2022

Aug 16, 2024

BUY
$31.52 - $373.61 $131,532 - $1.56 Million
4,173 Added 378.68%
5,275 $169 Million
Q2 2022

Aug 16, 2024

SELL
$26.83 - $38.57 $82,904 - $119,181
-3,090 Reduced 73.71%
1,102 $35.8 Million
Q1 2022

Aug 16, 2024

BUY
$30.95 - $39.68 $35,313 - $45,274
1,141 Added 37.4%
4,192 $152 Million
Q4 2021

Aug 16, 2024

BUY
$35.87 - $47.12 $30,597 - $40,193
853 Added 38.81%
3,051 $121 Million
Q3 2021

Aug 16, 2024

SELL
$41.55 - $48.72 $484,306 - $567,880
-11,656 Reduced 84.13%
2,198 $96.1 Million
Q2 2021

Aug 16, 2024

BUY
$32.88 - $44.57 $47,281 - $64,091
1,438 Added 229.71%
2,064 $84.3 Million
Q1 2021

Aug 16, 2024

BUY
$30.92 - $44.4 $525 - $754
17 Added 2.79%
626 $20.6 Million
Q4 2020

Aug 16, 2024

SELL
$33.66 - $40.76 $12,151 - $14,714
-361 Reduced 37.22%
609 $24.8 Million
Q3 2020

Aug 16, 2024

BUY
$33.07 - $38.68 $31,647 - $37,016
957 Added 7361.54%
970 $35.5 Million
Q2 2020

Aug 16, 2024

SELL
$20.05 - $33.89 $61,413 - $103,805
-3,063 Reduced 99.58%
13 $441,000
Q1 2020

Aug 16, 2024

BUY
$17.15 - $25.22 $7,065 - $10,390
412 Added 15.47%
3,076 $65.2 Million
Q4 2019

Aug 16, 2024

SELL
$18.88 - $24.14 $211,267 - $270,126
-11,190 Reduced 80.77%
2,664 $59.5 Million

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $15.2B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.